Related Experiment Video
Updated: Apr 27, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Patent foramen ovale and cryptogenic stroke: many unanswered questions
Christopher Roth1, Oluseun Alli2
1Instructor of Medicine, Department of Internal Medicine, University of Alabama at Birmingham Roth007@uab.edu.
Insights
Patent foramen ovale (PFO) is linked to cryptogenic stroke, but optimal management remains unclear. While PFO closure is safe, its superiority over medical therapy needs further proof.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Patent foramen ovale (PFO) is a known risk factor for cryptogenic stroke.
- The precise relationship between PFO and stroke, and optimal treatment strategies, are subjects of ongoing research and clinical debate.
Purpose of the Study:
- To review the current understanding of the association between PFO and cryptogenic stroke.
- To evaluate the safety, efficacy, and comparative effectiveness of PFO closure versus medical therapy for cryptogenic stroke.
Main Methods:
- Literature review of studies investigating PFO closure and medical management for cryptogenic stroke.
- Analysis of data on procedural safety, stroke recurrence rates, and patient outcomes.
Main Results:
- Percutaneous PFO closure is established as a safe and effective procedure.
- Definitive evidence proving the superiority of PFO closure over medical therapy for all patients with cryptogenic stroke is still lacking.
Conclusions:
- The management of cryptogenic stroke in patients with PFO presents challenges for clinicians.
- Further research is needed to clarify the comparative effectiveness of PFO closure and medical therapy to guide clinical decision-making.
Abstract:
Patent foramen ovale (PFO) is associated with cryptogenic stroke, but uncertainty remains about the exact relationship and the best management. Percutaneous closure of PFO is safe and effective, but this procedure has yet to be definitely proven to be better than medical therapy. The scenario of PFO and cryptogenic stroke poses unique challenges to primary care physicians and subspecialists and requires an understanding of the relationship between cryptogenic stroke and PFO, and of current data on the safety, efficacy, and comparative effectiveness of management options.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke l: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

